[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369760-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369760-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","deciphering-functional-landscape-and-clinical-implications-of-enhancer-rnas-in-lung-adenocarcinoma","Deciphering functional landscape and clinical implications of enhancer RNAs in lung adenocarcinoma","","Lung adenocarcinoma (LUAD) is a lethal lung cancer subtype with high mortality and limited therapies. Enhancer RNAs (eRNAs) emerged as regulators in cancer biology, yet their LUAD-specific functions remained unclear. This study integrated bioinformatics and experiments to identify differentially expressed eRNAs linked to LUAD progression, analyze their roles in pathways governing growth, division, repair, immunity, and tumor development, and build eRNA-centered regulatory networks involving transcription factors, enhancer-promoter loops, and RNA-binding proteins.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deciphering-functional-landscape-and-clinical-implications-of-enhancer-rnas-in-lung-adenocarcinoma/369760/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deciphering-functional-landscape-and-clinical-implications-of-enhancer-rnas-in-lung-adenocarcinoma/369760.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study on eRNAs in LUAD?","Question",{"text":63,"@type":64},"To investigate the role of enhancer RNAs in LUAD pathogenesis and assess their potential as diagnostic biomarkers and therapeutic targets.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were key eRNAs and their regulatory mechanisms identified?",{"text":68,"@type":64},"Differentially expressed eRNAs were identified using integrated bioinformatics and experimental approaches, followed by functional analysis and construction of eRNA-centric regulatory networks.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic tool did the researchers develop?",{"text":72,"@type":64},"A diagnostic prediction model based on eRNA expression profiles, designed to evaluate diagnostic accuracy for LUAD.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369760,1790242178,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDeciphering functional landscape and clinical implications of enhancer RNAs in lung adenocarcinoma  \nAike Li1,3, Liguang Zhang1,3, Xinsheng Du1, Yi Dong1, Yan Guo1, Jiwei Zhao1, Xiuli Fang2 & Pingping Lin1􀀍  \nLung adenocarcinoma (LUAD) is a common and deadly subtype of lung cancer with high mortality and limited treatment options. Enhancer RNAs (eRNAs) have emerged as important regulators in cancer biology, but their specific roles in LUAD have not been fully explored. This study aimed to investigate the role of eRNAs in LUAD pathogenesis and evaluate their potential as diagnostic biomarkers and therapeutic targets. Through integrated bioinformatics and experimental approaches, we identified differentially expressed eRNAs associated with LUAD progression. Functional analysis demonstrated that these eRNAs regulate critical pathways related to cell growth, division, repair, immune response, and tumor development. We constructed eRNA-centric regulatory networks, elucidating their interactions with transcription factors, enhancer-promoter loops, and RNA-binding proteins. Notably, eRNA ENSR00000188682 was highlighted for its central role, along with its associated transcription factor and downstream target gene ADRB2. Additionally, we developed a diagnostic prediction model based on eRNA expression profiles, which showed promising diagnostic accuracy. Our findings provide a comprehensive understanding of eRNA-mediated regulation in LUAD and suggest that eRNAs hold significant potential as prognostic biomarkers and therapeutic targets for improved clinical outcomes.  \nKeywords Lung adenocarcinoma (LUAD), Enhancer RNAs (eRNAs), Bioinformatics, Transcription factor (TF)  \nLung cancer, a prevailing malignancy globally, stands as the foremost cause of cancer-related mortality1,2. Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), together constituting non-small cell lung cancer (NSCLC), dominate its landscape3,4. LUAD, in particular, commands nearly 40% of lung cancer cases worldwide, experiencing a steady rise in incidence alongside diminished overall survival rates vis-à-vis its counterparts5,6. Thus, unraveling its mechanistic intricacies and forging precise diagnostic maodalities endure as formidable imperatives.  \nOnce relegated to the realm of \"junk DNA,\" non-coding regions of the human genome, encompassing roughly 98% of its expanse, have undergone a paradigmatic shift in perception7–9. High-throughput sequencing has revealed the vital functions of non-coding RNAs in various biological processes. Enhancer RNAs (eRNAs), transcribed from enhancers, play significant roles in gene regulation by forming chromatin loops with target promoters10 and are linked with active enhancer modifications like H3K27ac and H3K27me11, 12. Research increasingly highlights eRNAs as potential biomarkers and therapeutic targets in diseases such as cancer, neurodegenerative, and cardiovascular diseases13–16. Their disease-specific expression patterns and regulatory plasticity make them particularly attractive as therapeutic targets, enabling selective modulation of pathogenic pathways while sparing normal physiology.  \nImportantly, eRNAs have been shown to influence various signaling pathways, including G protein-coupled receptor (GPCR) signaling, which plays a pivotal role in tumor biology. One such key GPCR family member is the β2-adrenergic receptor (β2-AR), encoded by ADRB2, which regulates cell proliferation, immune responses, and metastasis in cancers including LUAD.  \nADRB2 encodes the β2-adrenergic receptor (β2-AR), a member of the G protein-coupled receptor superfamily (GPCR)17. Its dysregulation has been implicated in tumor biology, including processes such as  \n1Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei, China. 2Xinglong County People’s Hospital, Chengde 067300, Hebei, China. 3Aike Li and Liguang Zhang contributed equa","cbCaisdzQ2LwyVTT","https://ap.wps.com/l/cbCaisdzQ2LwyVTT","pdf",3359858,14,"English","# Methods\n## Data sources\n## ChIP-seq data processing\n## Differentially expressed eRNAs identification","[{\"question\":\"What was the main objective of the study on eRNAs in LUAD?\",\"answer\":\"To investigate the role of enhancer RNAs in LUAD pathogenesis and assess their potential as diagnostic biomarkers and therapeutic targets.\"},{\"question\":\"How were key eRNAs and their regulatory mechanisms identified?\",\"answer\":\"Differentially expressed eRNAs were identified using integrated bioinformatics and experimental approaches, followed by functional analysis and construction of eRNA-centric regulatory networks.\"},{\"question\":\"What diagnostic tool did the researchers develop?\",\"answer\":\"A diagnostic prediction model based on eRNA expression profiles, designed to evaluate diagnostic accuracy for LUAD.\"}]","Deciphering functional landscape and clinical implications of enhancer RNAs in lung adenocarcinoma | PDF",1790184391,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2645924fc224f99871521aad7faf0ca6.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb5f6fe00b7f7f81ae5ae344197b8af9.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/610c56c2754a9dc4dd7d4c3d761c3414.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02d159444a476f41626d8cbed1eb7d73.webp",980,1287]